Back to All Articles
Browse articles with tag: Biologics
You must be logged in to create a new article
All Articles
Pedram Sameni
Sep 22, 2022
•
ANDA Litigation
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Pedram Sameni
Sep 15, 2022
•
ANDA Litigation
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by... Read More
Knobbe Martens
Dec 4, 2017
•
Featured
Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar,(1) ... Read More
Knobbe Martens
Feb 3, 2017
•
Featured
Supreme Court Grants Certiorari in Amgen v. Sandoz
Written by Robert J. Hilton, Ph.D. and Jing Liu, Ph.D. On January 13, 2017, the Supreme Court granted certiorari in... Read More
Valerie Clark
Feb 16, 2012
•
Featured
FDA offers new guidance for evaluating generic biological products
Biological pharmaceuticals are therapeutic drugs made from human or animal materials rather than chemicals, often indicated for immune system-related deficiencies.... Read More